“HeartFlow has made outstanding progress under John’s leadership due to his dedication to the company and the physicians and patients served by HeartFlow,” said William C. Weldon, former Chairman of the Board of Directors, HeartFlow. “We are looking forward to working with Dana as the company takes an important next step towards becoming the standard of care for patients with coronary artery disease.”
Mead currently serves on the Board of Directors of Inspire Medical (NYSE:INSP), Intersect ENT (NASDAQ:XENT), BVI and Pulmonx, and has served on the boards of the California Healthcare Institute and Lucile Packard Children’s Hospital at Stanford University, and as chair of the Lafayette College West Coast Advisory Council. A native of Connecticut, Mead received his B.A. degree from Lafayette College and holds an M.B.A. from the University of Southern California.
Ad Statistics
Times Displayed: 114615
Times Visited: 6802 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About HeartFlow, Inc.
HeartFlow, Inc. is a digital health company uniquely positioned at the intersection of advanced artificial intelligence and healthcare to transform how heart disease is diagnosed and treated. Our non-invasive HeartFlow FFRct Analysis leverages deep learning to create a personalized 3D model of the heart. By using this model, clinicians can better evaluate the impact a blockage has on blood flow and determine the best treatment for patients. Our technology is reflective of our Silicon Valley roots and incorporates decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRct Analysis is commercially available in the United States, Canada, Europe and Japan.
Back to HCB News
